We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Dow Tells High Court Patent Definiteness Findings Require Review Under Teva

(May 12, 2016, 1:48 PM EDT) -- WASHINGTON, D.C. — A jury’s findings of fact subsidiary to the issue of patent definiteness require appellate review under the reasoning of Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc. (135 S.Ct....
To view the full article, register now.